199 related articles for article (PubMed ID: 35419808)
1. Cinnamic acid hybrids as anticancer agents: A mini-review.
Feng LS; Cheng JB; Su WQ; Li HZ; Xiao T; Chen DA; Zhang ZL
Arch Pharm (Weinheim); 2022 Jul; 355(7):e2200052. PubMed ID: 35419808
[TBL] [Abstract][Full Text] [Related]
2. Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure-activity relationship, and mechanisms of action (2019-2021).
Feng LS; Su WQ; Cheng JB; Xiao T; Li HZ; Chen DA; Zhang ZL
Arch Pharm (Weinheim); 2022 Jun; 355(6):e2200051. PubMed ID: 35385159
[TBL] [Abstract][Full Text] [Related]
3. Anticancer agents derived from natural cinnamic acids.
Su P; Shi Y; Wang J; Shen X; Zhang J
Anticancer Agents Med Chem; 2015; 15(8):980-7. PubMed ID: 25634446
[TBL] [Abstract][Full Text] [Related]
4. Coumarin-containing hybrids and their anticancer activities.
Zhang L; Xu Z
Eur J Med Chem; 2019 Nov; 181():111587. PubMed ID: 31404864
[TBL] [Abstract][Full Text] [Related]
5. Recent updates on 1,2,3-, 1,2,4-, and 1,3,5-triazine hybrids (2017-present): The anticancer activity, structure-activity relationships, and mechanisms of action.
Dong G; Jiang Y; Zhang F; Zhu F; Liu J; Xu Z
Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200479. PubMed ID: 36372519
[TBL] [Abstract][Full Text] [Related]
6. 1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
Xu Z; Zhao SJ; Liu Y
Eur J Med Chem; 2019 Dec; 183():111700. PubMed ID: 31546197
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of cinnamic amide derivatives and their anti-melanogenic effect in α-MSH-stimulated B16F10 melanoma cells.
Ullah S; Kang D; Lee S; Ikram M; Park C; Park Y; Yoon S; Chun P; Moon HR
Eur J Med Chem; 2019 Jan; 161():78-92. PubMed ID: 30347330
[TBL] [Abstract][Full Text] [Related]
8. Design and Synthesis of Molecular Hybrids of Sophora Alkaloids and Cinnamic Acids as Potential Antitumor Agents.
Shang H; Li L; Ma L; Tian Y; Jia H; Zhang T; Yu M; Zou Z
Molecules; 2020 Mar; 25(5):. PubMed ID: 32150948
[TBL] [Abstract][Full Text] [Related]
9. Current development of pyrazole-azole hybrids with anticancer potential.
Zhang S; Ye Y; Zhang Q; Luo Y; Wang ZC; Wu YZ; Zhang XP; Yi C
Future Med Chem; 2023 Aug; 15(16):1527-1548. PubMed ID: 37610862
[TBL] [Abstract][Full Text] [Related]
10. Current scenario of pyrazole hybrids with in vivo therapeutic potential against cancers.
Xu Z; Zhuang Y; Chen Q
Eur J Med Chem; 2023 Sep; 257():115495. PubMed ID: 37209450
[TBL] [Abstract][Full Text] [Related]
11. Cinnamic acid derivatives as anticancer agents-a review.
De P; Baltas M; Bedos-Belval F
Curr Med Chem; 2011; 18(11):1672-703. PubMed ID: 21434850
[TBL] [Abstract][Full Text] [Related]
12. Isatin-azole hybrids and their anticancer activities.
Hou Y; Shang C; Wang H; Yun J
Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900272. PubMed ID: 31691360
[TBL] [Abstract][Full Text] [Related]
13. Cinnamate Hybrids: A Unique Family of Compounds with Multiple Biological Activities.
Pontiki E; Peperidou A; Fotopoulos I; Hadjipavlou-Litina D
Curr Pharm Biotechnol; 2018; 19(13):1019-1048. PubMed ID: 30417783
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of the novel oleanolic acid-cinnamic acid ester derivatives and glycyrrhetinic acid-cinnamic acid ester derivatives with cytotoxic properties.
Wang R; Yang W; Fan Y; Dehaen W; Li Y; Li H; Wang W; Zheng Q; Huai Q
Bioorg Chem; 2019 Jul; 88():102951. PubMed ID: 31054427
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in isatin hybrids as potential anticancer agents.
Ding Z; Zhou M; Zeng C
Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900367. PubMed ID: 31960987
[TBL] [Abstract][Full Text] [Related]
16. Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure-activity relationship.
Gao F; Huang G; Xiao J
Med Res Rev; 2020 Sep; 40(5):2049-2084. PubMed ID: 32525247
[TBL] [Abstract][Full Text] [Related]
17. Hydroxamic acid hybrids as the potential anticancer agents: An Overview.
Liu W; Liang Y; Si X
Eur J Med Chem; 2020 Nov; 205():112679. PubMed ID: 32791404
[TBL] [Abstract][Full Text] [Related]
18. Current status of carbazole hybrids as anticancer agents.
Wang G; Sun S; Guo H
Eur J Med Chem; 2022 Feb; 229():113999. PubMed ID: 34838335
[TBL] [Abstract][Full Text] [Related]
19. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
20. The current scenario on anticancer activity of artemisinin metal complexes, hybrids, and dimers.
Zhang S; Yi C; Li WW; Luo Y; Wu YZ; Ling HB
Arch Pharm (Weinheim); 2022 Aug; 355(8):e2200086. PubMed ID: 35484335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]